Central Pacific Bank - Trust Division’s Vertex Pharmaceuticals VRTX Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54M	Buy	5,123 +97	+2%	+$43K	0.26%	93
2026 Q1	$2.24M	Hold	5,026	–	–	0.29%	91
2025 Q4	$2.28M	Buy	5,026 +24	+0.5%	+$10.3K	0.28%	92
2025 Q3	$1.96M	Sell	5,002 -557	-10%	-$233K	0.24%	107
2025 Q2	$2.47M	Buy	5,559 +134	+2%	+$61.8K	0.32%	86
2025 Q1	$2.63M	Buy	5,425 +272	+5%	+$127K	0.36%	71
2024 Q4	$2.08M	Sell	5,153 -3,550	-41%	-$1.65M	0.27%	87
2024 Q3	$4.05M	Buy	8,703 +258	+3%	+$124K	0.51%	33
2024 Q2	$3.96M	Buy	8,445 +69	+0.8%	+$29.9K	0.47%	36
2024 Q1	$3.52M	Buy	+8,376	New	+$3.54M	0.44%	40

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Central Pacific Bank - Trust Division's VRTX Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q2 2026, buying an estimated $43K and bringing the position to 5,123 shares worth $2.54M. The position accounts for 0.26% of the portfolio, ranked #93.

Central Pacific Bank - Trust Division first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.05M in Q3 2024. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Central Pacific Bank - Trust Division held 5,123 shares of Vertex Pharmaceuticals worth $2.54M as of Q2 2026.
Central Pacific Bank - Trust Division bought 97 Vertex Pharmaceuticals shares in Q2 2026, an estimated $43K.
Vertex Pharmaceuticals made up 0.26% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #93 holding.
Central Pacific Bank - Trust Division first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Central Pacific Bank - Trust Division's Vertex Pharmaceuticals position peaked at $4.05M in Q3 2024.
334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.